Product Information
FOCALIN XR 25 MG CAPSULE is a brand product labeled by Sandoz Inc., priced at $5.1431 per EA under NDC 66758023931. Its NADAC has been published 38 times since Jan 14, 2026.
FDA first approved this application on May 26, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the dexmethylphenidate hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
25 mg/1
Manufacturer
Sandoz Inc.NDC
66758023931
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXMETHYLPHENIDATE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021802FDA Approved
5/26/2005
TE Code
AB
On Market Since
5/31/2005
Pharmacological Classes
Price Statistics
The NADAC for FOCALIN XR 25 MG CAPSULE has been published 38 times since Jan 14, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.1431 per EA |
|---|---|
| All-time high | $5.1431 (Sep 30, 2026) |
| All-time low | $5.1291 (Jul 22, 2026) |
| 52-week high | $5.1431 |
| 52-week low | $5.1291 |
| Median price | $5.1418 |
| Average price | $5.1394 |
| Largest weekly change | -0.2% (Jul 22, 2026) |
| Weeks tracked | 38 |
| Tracking since | Jan 14, 2026 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 66% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dexmethylphenidate hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FOCALIN XR 25 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FOCALIN XR 25 MG CAPSULE, manufactured by Sandoz Inc., is $5.1431 per EA (NDC 66758023931), effective Sep 30, 2026.
How has the price of FOCALIN XR 25 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FOCALIN XR 25 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 38 weekly CMS publications since Jan 14, 2026.
What are the highest and lowest recorded NADAC prices for FOCALIN XR 25 MG CAPSULE?
Since Jan 14, 2026, the NADAC for FOCALIN XR 25 MG CAPSULE has ranged from a low of $5.1291 (Jul 22, 2026) to a high of $5.1431 (Sep 30, 2026), with a median of $5.1418 per EA.
Are there cheaper alternatives to FOCALIN XR 25 MG CAPSULE?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXMETHYLPHENIDATE ER 25 MG CP, is $1.7580 per EA — about 66% below FOCALIN XR 25 MG CAPSULE.
Who manufactures FOCALIN XR 25 MG CAPSULE?
FOCALIN XR 25 MG CAPSULE (NDC 66758023931) is labeled by Sandoz Inc., and CMS classifies it as a brand product.